Oxford Cannabinoid Technologies Holdings Plc Stock
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3625 GBX | -2.03% | +8.21% | -42.00% |
Apr. 11 | Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment | AN |
Apr. 09 | Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.03M 5.04M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.5M | Net income 2025 * | -3M -3.75M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.18M 1.48M | Net Debt 2025 * | 2.03M 2.54M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.68
x | P/E ratio 2025 * |
-1.28
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
1 day | -2.03% | ||
1 week | +8.21% | ||
Current month | -15.70% | ||
1 month | -15.70% | ||
3 months | -46.30% | ||
6 months | -50.00% | ||
Current year | -42.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | - | |
Paul Smalley
DFI | Director of Finance/CFO | - | 22-10-16 |
Chief Tech/Sci/R&D Officer | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Julie Pomeroy
CHM | Chairman | 69 | - |
Timothy Corn
CTO | Chief Tech/Sci/R&D Officer | 73 | 23-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.3625 | -2.03% | 2 816 890 |
24-04-25 | 0.37 | +1.37% | 8,086,943 |
24-04-24 | 0.365 | +4.29% | 25,074,210 |
24-04-23 | 0.35 | 0.00% | 3,621,379 |
24-04-22 | 0.35 | +4.48% | 13,731,010 |
Delayed Quote London S.E., April 26, 2024 at 05:37 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.00% | 5.03M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.81% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- OCTP Stock